Rivastigmine Transdermal System
- Product NDC
- 72162-1609
- 11-digit product format
- 721621609
- Labeler code
- 72162
- Product ID
- 72162-1609_99b5f8a0-5111-41c7-841b-cfa7ff27b4f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA209063
- Marketing category
- ANDA
- Marketing start
- 2019-12-19
- Substance
- RIVASTIGMINE
- Active strength
- 9.5 mg/24h
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rivastigmine Transdermal System
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIVASTIGMINE | 9.5 mg/24h |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | PKI06M3IW0 |
| Rxcui | 725023 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72162-1609-3 | Rivastigmine Transdermal System | 30 h in 1 PATCH | PATCH, EXTENDED RELEASE | 30 | | 100 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72162-1609 | RIVASTIGMINE TRANSDERMAL SYSTEM (RIVASTIGMINE) PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 100 | Current NDC, 1 package rows | 20241228_1ebeb8ec-5348-4bb1-ab3d-834690351094.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72162-1609-3 | 72162160903 | 30 h in 1 PATCH (72162-1609-3) | 30 h | 2024-12-24 | No | No | Current |